Journal Home
Search for

Volume 161, Issue 2, Pages 159-163 (September 2005)


View previous. 12 of 18 View next.

Jumping translocations in multiple myeloma

Déborah Jametab1, Youna Marzinab1, Nathalie Douet-Guilbertab, Frédéric Morelab, Marie-Josée Le Brisb, Angèle Herryab, Said Banzakourc, Pascal Bourquardc, Patrick Moricec, Jean François Abgralld, Christian Berthoue, Marc De BraekeleerabCorresponding Author Informationemail address

Received 27 December 2004; received in revised form 21 January 2005; accepted 31 January 2005.

Abstract 

Jumping translocations (JT) have been defined as nonreciprocal translocations involving a same donor chromosome arm or chromosome segment onto two or more recipient chromosomes in different cell lines in the same patient, leading to a mosaic karyotype. This definition has been expanded to also include extra copies of a same donor segment on different recipient chromosomes in a single clone. Six patients with multiple myeloma and JT involving chromosome arm 1q were identified among 37 patients presenting with chromosome 1 abnormalities. All six patients had an advanced disease and a short survival. The literature review allowed us to identify 24 additional patients with JT. Chromosomes 16 and 19 were the recipients in 11 (45.8%) and 6 (25%) of these 24 patients, respectively. Breakpoints on the recipient chromosomes were pericentromeric in 46.2% and telomeric in 40.4% of the breakpoints recorded. Since telomeres are made of (TTAGGG)n tandem DNA repeats that are also found in the pericentromeric heterochromatic regions (interstital telomeric sequences), it is presumed that jumping translocations arise through illegimate recombination between telomere repeat sequences and interstitial telomeric sequences.

a Laboratoire d'Histologie, Embryologie et Cytogénétique, Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, 22 Avenue Camille Desmoulins, Brest cedex F-29285, France

b Service de Cytogénétique, Cytologie et Biologie de la Reproduction, Centre Hospitalo-Universitaire Morvan, Avenue Foch, 29609 Brest, France

c Service d'Hématologie, Centre Hospitalier Yves Le Foll, BP 2367, 22023 St. Brieuc, France

d Service d'Hématologie Biologique

e Service d'Hématologie Clinique, Institut de Cancérologie et d'Hématologie, Centre Hospitalo-Universitaire Morvan, Avenue Foch, 29609 Brest, France

Corresponding Author InformationCorresponding author. Tel.:+33 (0)2 98 01 64 76; fax:+33 (0)2 98 01 81 89.

1 Both of these authors contributed equally to this work.

PII: S0165-4608(05)00095-6

doi:10.1016/j.cancergencyto.2005.01.017


View previous. 12 of 18 View next.